metricas
covid
Gastroenterología y Hepatología (English Edition) Vedolizumab, an option in patients with inflammatory bowel disease intolerant to...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents
Vedolizumab, una opción en pacientes con enfermedad inflamatoria intestinal intolerantes a tiopurinas y refractarios a biológicos
Marisa Iborraa, Belén Beltrána,
Corresponding author
belenbeltranniclos@gmail.com

Corresponding author.
, Nuria Marotob, Pablo Navarro-Cortésc, Maia Boscá-Wattsc, Isabel Ferrer-Bradleyb, Natalia García-Moralesa, Esteban Sáez-Gonzáleza, Joaquín Hinojosab, Miguel Mínguezc, Pilar Nosa
a Departamento de Gastroenterología, Hospital Universitari i Politecnic La Fe, CiberEHD, Valencia, Spain
b Departamento de Gastroenterología, Hospital de Manises, Valencia, Spain
c Departamento de Gastroenterología, Hospital Clinic Universitari de Valencia, Valencia, Spain
Read
3289
Times
was read the article
498
Total PDF
2791
Total HTML
Share statistics
Article information
ISSN: 24443824
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 77 3 80
2025 11 345 24 369
2025 10 97 4 101
2025 9 90 16 106
2025 8 121 12 133
2025 7 141 8 149
2025 6 57 4 61
2025 5 48 6 54
2025 4 34 3 37
2025 3 42 8 50
2025 2 49 6 55
2025 1 33 3 36
2024 12 43 3 46
2024 11 52 5 57
2024 10 37 5 42
2024 9 54 0 54
2024 8 41 4 45
2024 7 12 4 16
2024 6 21 1 22
2024 5 14 4 18
2024 4 32 6 38
2024 3 49 5 54
2024 2 25 3 28
2024 1 18 3 21
2023 12 43 2 45
2023 11 37 10 47
2023 10 52 2 54
2023 9 21 3 24
2023 8 15 2 17
2023 7 27 1 28
2023 6 27 2 29
2023 5 64 3 67
2023 4 59 6 65
2023 3 49 5 54
2023 2 35 7 42
2023 1 35 2 37
2022 12 31 6 37
2022 11 21 14 35
2022 10 26 11 37
2022 9 23 16 39
2022 8 38 24 62
2022 7 26 12 38
2022 6 24 26 50
2022 5 23 8 31
2022 4 27 5 32
2022 3 13 11 24
2022 2 26 14 40
2022 1 56 12 68
2021 12 41 13 54
2021 11 27 9 36
2021 10 24 14 38
2021 9 11 11 22
2021 8 41 12 53
2021 7 13 3 16
2021 6 18 13 31
2021 5 18 5 23
2021 4 78 18 96
2021 3 48 15 63
2021 2 41 10 51
2021 1 33 7 40
2020 12 39 16 55
2020 11 27 8 35
2019 1 2 0 2
Show all

Follow this link to access the full text of the article